印度批准两项新的本土结核病测试, India approves two new homegrown TB tests for faster, cheaper, easier diagnosis.

印度的ICMR已经批准了由Huwel生命科学公司(Huwel Life Sciences)进行的两项新的本土结核病诊断:Quantiplus MTB FAST工具包(Quantiplus MTB FAST)和UniAMP MTB测试卡(UniAMP MTB 测试卡),前者使用舌网,而不是用于更方便、非侵入性测试(特别是针对儿童和老年病人的测试),后者是一个与标准实验室机器兼容的开放系统RT-PCR测试,可同时处理96个样本,并将成本降低20%。 India’s ICMR has approved two new homegrown TB diagnostics by Huwel Lifesciences: the Quantiplus MTB FAST kit, an open-system RT-PCR test compatible with standard lab machines that can process 96 samples at once and cut costs by up to 20%, and the UniAMP MTB Test Card, which uses tongue swabs instead of sputum for easier, non-invasive testing—especially for children and elderly patients. 这些工具扩大了获得快速、准确的肺结核检测的机会,支持社区和门前筛查,并加强了印度消灭肺结核的努力。 These tools expand access to rapid, accurate TB detection, support community and doorstep screening, and strengthen India’s push to eliminate TB.